| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.22 | 4e-05 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.45 | 0.003 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.1 | 0.02 |